» Articles » PMID: 17962640

Gene Transfer of Extracellular Superoxide Dismutase Ameliorates Pulmonary Hypertension in Rats

Overview
Specialty Critical Care
Date 2007 Oct 27
PMID 17962640
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Pulmonary hypertension (PH) is a life-threatening disease, characterized by vascular remodeling and vasoconstriction. Evidence suggests that oxidative stress may contribute to the pathogenesis and/or development of PH.

Objectives: In the present study, we examined whether intratracheal gene transfer of human extracellular superoxide dismutase (EC-SOD) could ameliorate monocrotaline (MCT)-induced PH in rats.

Methods: MCT-injected rats were intratracheally administered vehicle (MCT group) or an adenovirus encoding beta-galactosidase (Adbetagal group) or human EC-SOD (AdEC-SOD group).

Measurements And Main Results: After intratracheal gene transfer, EC-SOD was successfully expressed in lung tissue, bronchoalveolar lavage fluid, and plasma. Twenty-eight days after MCT injection, right ventricular systolic pressure and the weight ratio of the right ventricle to the left ventricle plus septum were significantly lower in the AdEC-SOD group (42.50 +/- 1.46 mm Hg and 0.453 +/- 0.029, respectively) than in the MCT group (59.89 +/- 1.61 mm Hg and 0.636 +/- 0.022, respectively) or the Adbetagal group (61.50 +/- 2.61 mm Hg and 0.653 +/- 0.038, respectively). Moreover, vascular remodeling and proliferation of vascular smooth muscle cells in pulmonary arteries were markedly suppressed in the AdEC-SOD group. Importantly, 8-isoprostane in lung tissue was also significantly reduced in the AdEC-SOD group.

Conclusions: EC-SOD overexpression to the lung ameliorated MCT-induced PH in rats. We suggest that EC-SOD may act as an antioxidant in PH and that increased oxidative stress may be important in the pathogenesis of MCT-induced PH.

Citing Articles

Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling.

Fang Q, Bai Y, Hu S, Ding J, Liu L, Dai M Antioxidants (Basel). 2023; 12(11).

PMID: 38001831 PMC: 10669195. DOI: 10.3390/antiox12111978.


Oxidative Stress, Antioxidants and Hypertension.

Amponsah-Offeh M, Diaba-Nuhoho P, Speier S, Morawietz H Antioxidants (Basel). 2023; 12(2).

PMID: 36829839 PMC: 9952760. DOI: 10.3390/antiox12020281.


Silencing TUFM Inhibits Development of Monocrotaline-Induced Pulmonary Hypertension by Regulating Mitochondrial Autophagy via AMPK/mTOR Signal Pathway.

Wei R, Lv X, Fang C, Liu C, Ma Z, Liu K Oxid Med Cell Longev. 2022; 2022:4931611.

PMID: 35936222 PMC: 9348918. DOI: 10.1155/2022/4931611.


Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats.

Jiang W, Han X, Zhang Y, Xia Q, Zhang J, Wang F RSC Adv. 2022; 9(1):552-559.

PMID: 35521617 PMC: 9059326. DOI: 10.1039/c8ra07892k.


Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation.

Xie S, Deng Y, Guo S, Li J, Zhou Y, Liao J Sci Rep. 2022; 12(1):3056.

PMID: 35197507 PMC: 8866506. DOI: 10.1038/s41598-022-06848-7.